• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

“Mismatch” with opioid treatment, vulnerable communities, leaves patients at risk in disaster


Study examines locations, preparedness for pandemic, treatment disruptions.

“Mismatch” with opioid treatment, vulnerable communities, leaves patients at risk in disaster

A “mismatch” between opioid treatment locations and vulnerable communities across the United States could lead to disruptions in care for patients in times of disaster, according to a new study.

The COVID-19 pandemic has spiked the overdose death rate from opioid use. The pandemic or natural disasters such as tornados, hurricanes, and wildfires could disrupt access to buprenorphine, methadone, and extended-release naltrexone, medications for opioid use disorder (MOUDs), study authors Paul Joudrey, MD, MPH, and Emily Wang, MD, said in a press release.

“In plain terms, we are not placing enough services in communities that are more vulnerable to disasters and pandemics,” Joudrey said in a press release. “If a disaster disrupts medication services, people living within these communities are less likely to receive treatment.”

This mismatch between community vulnerability during disaster and the availability of services was the worst for vulnerable suburban communities -- a particularly unique finding, Joudrey said.

“We also found that in rural communities, because the availability of services was just bad all around, there was no association between vulnerability and access to medications,” said Joudrey, assistant professor of medicine and Yale Drug Use, Addiction, and HIV Research scholar.

The researchers analyzed locations of treatment facilities in 32,434 zip codes across the United States, compared with social vulnerability of residents. The social vulnerability index measures four themes: socioeconomic status; household composition and disabilities; racial and ethnic minority status and language; and housing type and transportation.

Across the nation, “zip codes with greater social vulnerability did not have greater geographic access to each of the three MOUDs, showing the degree to which the United States falls short of ensuring equitable access to all MOUDs, especially during natural disasters,” the study said.

Almost 25% of the population of the continental United States lives without access to the medications within a 30-minute drive.

The researchers said the findings confirm what has been reported in recent natural disasters.

“Hurricane Katrina, Hurricane Sandy, and Hurricane Maria showed that part of the deaths that occur following disasters such as those are because people's health services were disrupted,” said Wang, professor of medicine and of public health and director of the SEICHE Center for Health and Justice at Yale. “Our results show that preparedness has too long been only a practice for the middle and upper class. We need to think more deliberately about how preparedness for hurricanes and for COVID-19 includes those placed at highest risk.”

The study, “Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder,” was published in the journal JAMA Network Open.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice